Teladoc, Inc. (TDOC) Analysts See $-0.41 EPS

February 22, 2018 - By Migdalia James

 Teladoc, Inc. (TDOC) Analysts See $ 0.41 EPS

Analysts expect Teladoc, Inc. (NYSE:TDOC) to report $-0.41 EPS on February, 27 after the close.They anticipate $0.10 EPS change or 32.26 % from last quarter’s $-0.31 EPS. After having $-0.55 EPS previously, Teladoc, Inc.’s analysts see -25.45 % EPS growth. The stock increased 2.38% or $0.9 during the last trading session, reaching $38.65. About 1.14M shares traded. Teladoc, Inc. (NYSE:TDOC) has risen 205.04% since February 22, 2017 and is uptrending. It has outperformed by 188.34% the S&P500.

Teladoc, Inc. (NYSE:TDOC) Ratings Coverage

Among 18 analysts covering Teladoc Inc (NYSE:TDOC), 14 have Buy rating, 0 Sell and 4 Hold. Therefore 78% are positive. Teladoc Inc had 69 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Buy” rating by Deutsche Bank given on Friday, October 2. Cantor Fitzgerald maintained the stock with “Hold” rating in Monday, August 28 report. Piper Jaffray maintained it with “Buy” rating and $42.0 target in Monday, September 11 report. Piper Jaffray maintained Teladoc, Inc. (NYSE:TDOC) on Friday, February 9 with “Buy” rating. The stock of Teladoc, Inc. (NYSE:TDOC) earned “Buy” rating by SunTrust on Monday, July 27. The stock of Teladoc, Inc. (NYSE:TDOC) has “Buy” rating given on Wednesday, September 9 by Deutsche Bank. The rating was maintained by Cantor Fitzgerald on Monday, June 19 with “Hold”. Canaccord Genuity maintained Teladoc, Inc. (NYSE:TDOC) on Thursday, August 3 with “Buy” rating. As per Thursday, August 3, the company rating was maintained by Oppenheimer. The company was initiated on Friday, December 8 by Deutsche Bank.

Teladoc, Inc. operates a telehealth platform that provides on-demand healthcare services to its members in the United States. The company has market cap of $2.36 billion. The Company’s solution connects clients with its physicians and behavioral health professionals that treat a range of conditions and cases, including acute diagnoses, such as upper respiratory infection, urinary tract infection, and sinusitis; dermatological conditions; anxiety; and smoking cessation. It currently has negative earnings. The firm offers its services through mobile devices, the Internet, video, and phone.

More news for Teladoc, Inc. (NYSE:TDOC) were recently published by: Globenewswire.com, which released: “In Midst of Flu Epidemic, Teladoc Provides Relief for Overburdened Health System” on February 20, 2018. Globenewswire.com‘s article titled: “Teladoc to Announce Fourth Quarter and Full-Year 2017 Financial Results” and published on February 13, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: